Announced Fri, 14 Aug · 16:20 IST
Sanjivani Paranteral Q1 FY27: Income up 34%, PAT up 44%
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹196.00
prior close
₹193.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
——+3.1—+2.0+0.0-3.1-2.5——————
Up moveDown movePending
AI summary
Sanjivani Paranteral reported Q1 FY27 results with Total Income at ₹239.90 Mn (up 33.81% YoY). EBITDA rose 61.04% to ₹43.21 Mn, with margin expanding 305 Bps to 18.01%. PAT grew 43.94% to ₹24.91 Mn. Injectables led at ₹110.12 Mn (56.59% of revenue, up 22.54%). Exports dominated at 90.50% of revenue, growing 33.49% YoY.
Likely market impact
Strong quarterly performance with double-digit growth across income, EBITDA and PAT. Improving margins signal operational efficiency gains.